Review3 Biotech2022

COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review.

Faizan Zarreen Simnani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.